Oral Thin Films Market on Track for Strong Growth, Estimated to Grow at 14.7% CAGR Through 2029

Stay ahead with our updated market reports featuring the latest on tariffs, trade flows, and supply chain transformations._x000D_
_x000D_
What Is the Expected CAGR for the Oral Thin Films Market Through 2025?_x000D_
In recent times, the market size for oral thin films has seen swift expansion. There will be a surge from $4.48 billion in 2024 to $5.03 billion in 2025, showing a compound annual growth rate (CAGR) of 12.2%. The progress made over the historical period can be linked to factors such as the adherence to medication from patients, the rise in pediatric and geriatric patient groups, rapid medication delivery, the increase in chronic diseases, and over-the-counter (otc) medications._x000D_
_x000D_
What's the Projected Size of the Global Oral Thin Films Market by 2029?_x000D_
The market for oral thin films is predicted to experience a swift expansion in the coming years. It is projected to reach a value of $8.72 billion by 2029, with a Compound Annual Growth Rate (CAGR) of 14.7%. The anticipated growth during the forecast period can be linked to factors such as specialty pharmaceuticals, precision medicine, mental health medications, oral vaccines, and telemedicine services. Significant trends to watch during the forecast period encompass drug delivery technologies, remote healthcare, bioavailability improvement, travel and on-the-go application, and formulations free from allergens._x000D_
_x000D_
View the full report here:_x000D_
https://www.thebusinessresearchcompany.com/report/oral-thin-films-global-market-report_x000D_
_x000D_
Top Growth Drivers in the Oral Thin Films Industry: What's Accelerating the Market?_x000D_
The surge in the requirements for thin film therapeutic delivery systems is the major driving force behind the expansion of the oral thin film (OTF) market. Defined as fast-dissolving, convenient, and self-administrable, thin films have emerged as a promising substitute to traditional dosage forms and stand as an adaptable platform for drug delivery. Their oral intake and non-reliance on water for absorption make them a preferred choice for patients, chiefly due to their fast dissolution rate. Such increasing requirements for thin-film delivery systems are also spurring the demand for oral thin films. With more than half of the American population affected by cardiovascular diseases and the projection of a minimum of 42% of new cancer diagnoses, excluding non-melanoma skin cancer, amounting to around 820,000 cases in 2023 and 840,000 instances in 2024, the need for progressive drug delivery methods to ensure effective treatment is more pressing than ever in the United States, as per a January 2023 report by the non-profit The American Cancer Society. Therefore, the rising demand for thin film drug delivery systems indeed enhances the growth of the oral thin film market._x000D_
_x000D_
Get your free sample here:_x000D_
https://www.thebusinessresearchcompany.com/sample.aspx?id=6067&type=smp_x000D_
_x000D_
What Trends Will Shape the Oral Thin Films Market Through 2029 and Beyond?_x000D_
Major firms active in the oral thin film market are using innovative goods like Rizaport to bolster their market profits. Rizaport is a proprietary oral thin-film recipe comprising rizatriptan benzoate, a 5-HT1 receptor agonist, and the efficacious ingredient of Maxalt by Merck & Co. For example, in February 2024, CD Formulation, an American drug formulation firm, introduced the oral thin film technology. This offers an easy way of administration specifically for patients having trouble swallowing, and ensuring quick absorption by dissolving in the mouth, bypassing the digestive tract for a more immediate effect. This advanced drug dispersion scheme increases bioavailability, permits accurate dosage for personalized therapy, and boosts convenience and medication compliance, particularly in urgent circumstances._x000D_
_x000D_
What Are the Main Segments in the Oral Thin Films Market?_x000D_
The oral thin films market covered in this report is segmented -_x000D_
_x000D_
1) By Type: Sublingual Film, Fast Dissolving Dental/Buccal Film_x000D_
2) By Disease Indication: Schizophrenia, Migraine, Opioid Dependence, Nausea & Vomiting, Other Disease Indication_x000D_
3) By Distribution Channel: Hospital Pharmacies, Retail Pharmacies, Other Distribution Channels_x000D_
_x000D_
Subsegments:_x000D_
1) By Sublingual Film: Drug Delivery Films, Nutritional Supplement Films_x000D_
2) By Fast Dissolving Dental Or Buccal Film: Over-the-Counter (OTC) Products, Prescription Products_x000D_
_x000D_
Tailor your insights and customize the full report here:_x000D_
https://www.thebusinessresearchcompany.com/customise?id=6067&type=smp_x000D_
_x000D_
Which Top Companies are Driving Growth in the Oral Thin Films Market?_x000D_
Major companies operating in the oral thin films market include ZIM Laboratories Limited, NAL Pharma, Cure Pharmaceutical Holding Corp., IntelGenx Corp., Kyu Kyu Pharmaceutical Co. Ltd., Sunovion Pharmaceuticals Inc., Seoul Pharma Co. Ltd., Aquestive Therapeutics Inc., Shilpa Therapeutics Pvt. Ltd., Mylan Inc., LIVKON Pharmaceuticals Pvt. Ltd., Panacea Biotec Ltd., Adare Pharmaceuticals Inc., APR Applied Pharma Research SA, BioDelivery Sciences International Inc., Sumitomo Dainippon Pharma Co. Ltd., Indivior PLC, LTS Lohmann Therapie-Systeme AG, Tesa Labtec GmbH, Pfizer Inc., Sanofi S.A., Merck & Co. Inc., Novartis International AG, Roche Holding AG, Johnson & Johnson, GlaxoSmithKline plc, Bayer AG, Eli Lilly and Company, AbbVie Inc., Bristol-Myers Squibb Company, Novo Nordisk A/S, AstraZeneca plc_x000D_
_x000D_
Which Regions Will Dominate the Oral Thin Films Market Through 2029?_x000D_
North America was the largest region in the oral thin film market in 2024. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the oral thin films market report include Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East and Africa._x000D_
_x000D_
Purchase the full report today:_x000D_
https://www.thebusinessresearchcompany.com/purchaseoptions.aspx?id=6067_x000D_
_x000D_
This Report Supports:_x000D_
1. Business Leaders & Investors - To identify growth opportunities, assess risks, and guide strategic decisions._x000D_
2. Manufacturers & Suppliers - To understand market trends, customer demand, and competitive positioning._x000D_
3. Policy Makers & Regulators - To track industry developments and align regulatory frameworks._x000D_
4. Consultants & Analysts - To support market entry, expansion strategies, and client advisory work._x000D_
_x000D_

Connect with us on:
LinkedIn: https://in.linkedin.com/company/the-business-research-company,
Twitter: https://twitter.com/tbrc_info,
YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ.

Contact Us
Europe: +44 207 1930 708,
Asia: +91 88972 63534,
Americas: +1 315 623 0293 or
Email: mailto:info@tbrc.info

Learn More About The Business Research Company
With over 15,000+ reports from 27 industries covering 60+ geographies, The Business Research Company has built a reputation for offering comprehensive, data-rich research and insights. Our flagship product, the Global Market Model delivers comprehensive and updated forecasts to support informed decision-making.

This release was published on openPR.